Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | IMC-F106C |
Trade Name | |
Synonyms | IMC F106C|IMC F106C |
Drug Descriptions |
IMC-F106C is T-cell receptor, in fusion with anti-CD3 single-chain variable fragment, that targets cancer cells expressing PRAME (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C170976 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMC-F106C | IMC-F106C | 0 | 1 |
IMC-F106C + unspecified PD-1 antibody | IMC-F106C unspecified PD-1 antibody | 0 | 1 |
IMC-F106C + unspecified PD-L1 antibody | IMC-F106C unspecified PD-L1 antibody | 0 | 1 |